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In the recent review published in Brain Sciences, Othman and Tan suggested several
preconditioning strategies to improve stem cell therapy after ischemic brain injury [1].
They explored the regeneration efficacy of neural stem cells and introduced methods to
optimize cell-based therapies. Due to some limitations related to the usage of neural
stem cells, application of other pretreated cell types can also be beneficial for the ischemic
brain [2]. Our research group has been studying the regenerative potential of epidermal
neural crest stem cells (EPI-NCSCs) derived from hair follicles of rat and human since
2013 [3,4]. These multipotent stem cells are located in the bulge region of hair follicles
throughout adulthood (Figure 1A), are ontologically related to the nervous system and
present a high level of physiological plasticity [5]. Recently, we showed the therapeutic
effect of transplanted EPI-NCSCs in a rat model of ischemic stroke, most likely through the
simultaneous induction of neuronal and glial formation, as well as Bdnf overexpression.
In this study, administration of EPI-NCSCs via intra-arterial or intravenous routes imme-
diately after reperfusion, resulted in reduced infarct size seven days post transplantation
(Figure 1B) [6]. Our previous findings also demonstrated that cerebrospinal fluid can
be a practical route for the delivery of EPI-NCSCs [3]. Currently, our research group is
focusing on the intranasal administration of EPI-NCSCs and their conditioned medium in
the context of stroke. The preliminary data revealed that intranasal application of rat and
human derived EPI-NCSCs and their secretome could alleviate the devastating condition
following cerebral ischemia.
According to the work completed thus far, there are several preconditioning strategies
to overcome poor cell survival, uncontrolled cell maturity, inefficient delivery and low en-
graftment rate, prior to the utilization of stem cells as viable clinical therapy. These precon-
ditioning approaches, including hypoxic pretreatment, stem cell modification (neurotrophic
overexpression), and chemical or biomaterial assistance, improve stem cell therapy and
promote its clinical application.
The therapeutic benefit of hypoxic preconditioning applied to neural stem cells was
also reviewed by Othman and Tan. Hypoxic pretreatment triggers various protective sig-
naling pathways and increases cell survival and cytokine secretion. Interestingly, based on
low oxygen tension in the hair follicles, ranging between 2.5% and 0.1% O2 [7], EPI-NCSCs
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are inherently resistant to low oxygen conditions. Thus, hypoxic preconditioning can
mimic their physiological niche, which might improve their homing and neuroprotective
ability following transplantation. Using chemical agents to optimize stem cell therapy is an
approach where the evidence suggests that the application of various off-labelled drugs can
improve the restorative potential of transplanted stem cells in animal models of ischemic
stroke. Our previous experience supports this through the findings that small molecules, in-
cluding valproic acid [8,9], dimethyl fumarate [10], and fingolimod [11] and acetylsalicylic
acid (aspirin) can induce the expression of neurotrophic factors in EPI-NCSCs (Figure 1C).
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fibrillary acidic protein, BDNF: brain-derived neurotrophic factor, VPA: valproic acid, GDNF: glial cell-derived neu-
rotrophic factor, VEGF: vascular endothelial growth factor, DMF: dimethyl fumarate, NT3: neurotrophin-3. 
Another preconditioning strategy involves the in vitro formation of three-dimen-
sional (3D) stem cell aggregates that increase extracellular matrix secretion and promote 
their trophic functions. EPI-NCSCs can form spheres in vitro (Figure 1A) and transplan-
tation of these spheres may present several advantages over conventional engraftment. 
Othman and Tan also suggested applying an electrical current by means of conduc-
tive polymer to activate several intracellular signaling pathways in neural stem cells and 
Figure 1. A summary of epidermal neural crest stem cells (EPI-NCSCs) characterization (A), benefit in a rat model of
ischemic stroke (B), pretreatment with small molecules (C) and biomaterial assistance (D). DCX: doublecortin, GFAP: glial
fibrillary acidic protein, BDNF: brain-derived neurotrophic factor, VPA: valproic acid, GDNF: glial cell-derived neurotrophic
factor, VEGF: vascular endothelial growth factor, DMF: dimethyl fumarate, NT3: neurotrophin-3.
Another preconditioning strategy involves the in vitro formation of three-dimensional
(3D) stem cell aggregates that increase extracellular matrix secretion and promote their
trophic functions. EPI-NCSCs can form spheres in vitro (Figure 1A) and transplantation of
these spheres may present several advantages over conventional engraftment.
Othman and Tan also suggested applying an electrical current by means of conduc-
tive polymer to activate several intracellular signaling pathways in neural stem cells and
promote their differentiation. Besides electrical stimulation to manipulate cell behaviors
in vitro and in vivo, biomaterial assistance is an established preconditioning strategy to
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enhance stem cell function. Previously, we showed that providing a substrate with stiffness
similar to the central nervous system elasticity enables EPI-NCSCs to retain more mechani-
cal information about the future environment, which might improve their integration and
enhance their function in the damaged neural tissue. This preconditioning resulted in
overexpression of VEGF, NT3 and GDNF in these stem cells (Figure 1D) [12]. It is worth
noting that EPI-NCSCs express several trophic factors such as BDNF, GDNF, NT3, NGF,
and VEGF, all of which can benefit the inhospitable environment of the injured nervous
system [13].
Despite the popularity of cell-based therapy, tracking the transplanted stem cells and
evaluation of their therapeutic efficiency has been a major challenge in this field [14]. We
previously reported the successful transduction of EPI-NCSCs with lentiviral particles
encoding green fluorescent protein (Figure 1A), revealing some practical applications of
this technique for indirect tracking of EPI-NCSCs [15].
Taken together, the review of Othman and Tan offered potential preconditioning
strategies to improve neural stem cell transplantation. In parallel, we suggest EPI-NCSCs
as a promising cell type for transplantation after cerebral ischemia. The implementation of
the above-mentioned preconditioning modalities including hypoxic pretreatment, small
molecules and biomaterial assistance or their combination along with using a proper
route of administration can optimize the transplantation efficacy of EPI-NCSCs and their
curative potential.
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